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 Takotsubo cardiomyopathy is an acute
heart failure syndrome often triggered by
emotional or physical stress, where no
treatment currently exists, and exact
pathogenic mechanisms are unclear.
 Rats in which takotsubo-like cardiomyopathy
was induced showed localized myocardial
inﬂammatory changes, including progressive
inﬂammatory inﬁltrates and myoﬁber atro-
phy, that persisted over the 14-day time
course examined.
 Early neutrophil inﬁltrates were followed
by clusters of myocardial macrophages,
typically of an M1 proinﬂammatory
phenotype, with no switch to M2
resolving macrophages; individual M2
macrophage levels, however, correlated
with recovery in cardiac function. Human
post-mortem myocardial tissue shared
features of the experimental model
demonstrating M1 macrophage clusters.
 The persistent clinical symptoms and long-
term morbidity/mortality observed in takot-
subo patients may, in part, relate to chronic
nonresolving myocardial inﬂammation.https://doi.org/10.1016/j.jacbts.2018.08.006
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AB BAND ACRONYM S




MI = myocardial infarction
qPCR = quantitative
polymerase chain reaction
TNFa = tumor necrosis factor-
alphaTakotsubo cardiomyopathy is an acute stress-induced heart failure syndrome for which the exact pathogenic
mechanisms are unclear, and consequently, no speciﬁc treatment exists. In an experimental model of stress-
induced takotsubo-like cardiomyopathy, the authors describe the temporal course of a chronic inﬂammatory
response post-induction, with an initial early inﬂux of neutrophils into myocardial tissue followed by macro-
phages that are typical of a proinﬂammatory M1 phenotype, and a nonsigniﬁcant increase in systemic
inﬂammatory cytokines. Post-mortem myocardium from the more complex clinical takotsubo patients share
features of the study’s experimental model. These ﬁndings suggest modulators of inﬂammation could be
a potential therapeutic option. (J Am Coll Cardiol Basic Trans Science 2018;3:766–78) © 2018 The Authors.
Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SEE PAGE 779A cute stress-induced (takotsubo) cardiomyop-athy has a dramatic clinical presentation,mimicking a myocardial infarction (MI) (1)
and is often precipitated by major emotional/physical
stress. Despite unobstructed coronary arteries, the
left ventriculogram shows characteristic myocardial
ballooning, not corresponding to a single coronary
artery territory, and the heart function is severely
reduced. Regardless of a spontaneous process of re-
covery as a recognized feature of takotsubo cardio-
myopathy, the mortality risk and long-term
mortality are also comparable with MI (2,3). There is
no current treatment, and the etiology is unclear,
therefore its pathophysiology needs to be resolved
before targeted therapies can be trialed. We have pre-
viously demonstrated severe global edema in both
left and right ventricular myocardium of takotsubo
patients during the acute phase with incomplete res-
olution at 4 months (4–7). The substrate of this persis-
tent edema is most likely an ongoing inﬂammatory
response, which remains to be characterized in detail.
However, this is challenging in patients, where coex-
istent cardiac pathologies, lack of access to tissue,
very small biopsies that do not reﬂect global changes,
and tissue availability only at a single time point, are
the norm.
Here, we used a previously established and well-
reported rodent experimental model of catechol-
amine (stress)-induced takotsubo-like cardiac
dysfunction (8–12), where the disease process is
consistent and reproducible, and there are no con-
founding complications or major limitations to tissue
availability. Although it remains unclear whether a
“catecholamine surge” is fundamentally causal in
triggering human takotsubo cardiomyopathy, this
experimental model results in a similar wall motion
abnormality that is observed in the human disease in
the absence of an ischemic or infectious insult (8–12).
Our aim was to establish the type and time course ofthe myocardial inﬂammatory changes in this stress-
induced experimental model and to then determine
whether similar changes existed in viable, nonﬁbrotic
myocardium from necessarily more complex human
post-mortem cases. We speciﬁcally focused on
detecting and characterizing macrophages, a hetero-
geneous cell population that inﬁltrates damaged tis-
sue and functionally range between proinﬂammatory
(M1 macrophages) and anti-inﬂammatory/tissue
reparative/proﬁbrotic (M2 macrophages) subtypes
(13,14). Our results reveal, for the ﬁrst time to our
knowledge, a clear, localized, and temporal inﬂam-
matory response with a predominance of M1 proin-
ﬂammatory macrophages within rat myocardial tissue
following induction of takotsubo-like cardiomyopathy
and evidence for a similar process in more complex
human post-mortem cases. Unlike post-MI, there is no
switch to M2-resolving macrophages, and the per-
centage ofM2macrophages correlates with recovery of
cardiac function. This low-level, nonresolving
inﬂammation provides a rationale for an immuno-
mechanistically targeted therapeutic strategy in a
condition for which no current therapy is available.METHODS
ANIMALS. All animal work was performed in accor-
dance with the United Kingdom Home Ofﬁce regula-
tions and approved by Aberdeen University Animal
Ethics Committee. Female Sprague Dawley rats, 4 to 6
months old (due to better survival rates on disease
induction than in older rats), weighing 300  12 g
were housed in a temperature-controlled (25C) fa-
cility with a 12-h light/dark cycle and given free ac-
cess to food and water.
HUMAN POST-MORTEM SAMPLES. Research approval
for post-mortem hearts was obtained under family
Wilson et al. J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 6 , 2 0 1 8
Takotsubo Cardiomyopathy and Myocardial Inﬂammation D E C E M B E R 2 0 1 8 : 7 6 6 – 7 8
768consent for 2 female patients (69 and 54 years of age)
who died shortly after episodes of acute takotsubo
cardiomyopathy in Aberdeen Royal Inﬁrmary. Patient
1 presented with chest pain, and an electrocardiogram
showed 9-mm ST-segment elevation in inferior leads
and ST-segment depression in the corresponding
precordial leads; cardiac catheterization showed
normal coronary arteries and a large area of apical and
mid-cavity ballooning (Supplemental Figure 1A). She
died 5 h after presentation. Autopsy established api-
cal inferior myocardial rupture with tamponade and
50% stenosis of the right coronary ostium. Patient 2
had a previous, documented takotsubo event at a
family funeral 3 years before death, and presented at
another family funeral with chest pain. There was
anterior ST-segment elevation on electrocardiogram,
moderate stenosis in the right coronary artery on
catheterization, and apical ballooning on left ven-
triculogram (Supplemental Figure 1B). She died on
the ﬁfth day of admission, in torsade de pointes and
ventricular ﬁbrillation. Autopsy established patent
coronary arteries with moderate atheroma of the right
coronary artery and an old area of left ventricular
myocardial ﬁbrosis. Both patients had a modest,
disproportionately low biomarker (troponin) rise
relative to the large area of wall motion abnormality.
No recent infarction was noted on microscopy at au-
topsy. The myocardial tissue used for analysis was
from areas unaffected by ﬁbrosis. Four control heart
specimens with no known clinical or post-mortem
ﬁndings of heart disease were obtained from
archived cases. Formalin-ﬁxed myocardium (5-mm
sections) were examined by histology and immuno-
histochemistry and scored in a blinded fashion by
P.A.J.B. and N.D.
INDUCTION OF STRESS-INDUCED CARDIOMYOPATHY.
Rats received a single dose of 100 mg/kg isoprenaline
intraperitoneally, a protocol that induces reproduc-
ible takotsubo-like cardiac dysfunction (8–12) with
widespread akinesia or hypokinesia of apical seg-
ments and hypercontractility of the cardiac base in
85% of rats. This model results in supraphysiological
levels of circulating catecholamines, initial high
blood pressure and heart rates, and a high yield of
wall motion abnormality after the induced stress of
isoprenaline and thus provides a stress-induced
model in the absence of ischemic and pathogen-
induced inﬂammatory insults. Systolic regional wall
motion abnormalities in this model disappear be-
tween days 6 to 15 post-induction. Survival rates
following injection were 90%. Similar volumes of
intraperitoneal saline injections were given to the
control rat group. Rats were sacriﬁced serially on
day 0 (6 h after injection) and days 1 to 7 and day 14after disease induction, with group sizes as indicated
for each experimental analysis.
ECHOCARDIOGRAPHY. Echocardiography was per-
formed before sacriﬁcing rats to ascertain the pres-
ence of wall motion abnormality and to quantify the
cardiac function. A Vivid Q equipment (GE Health-
care, Oslo, Norway) with an 11.5-MHz pediatric probe
was used to acquire images. Rats were placed under
anesthesia (1.25% isoﬂurane in oxygen after 4% iso-
ﬂurane induction), and chests were shaved. One long-
axis and 3 short-axis views (base, mid, and apex) were
acquired. The duration of anesthesia did not exceed 2
min in any rat. Heart rate was 290  5 beats/min
during echocardiography (normal rate). Ejection
fraction (EF) was calculated using the area–length
method (15). Characteristics of experimental stress-
induced cardiomyopathy are shown in Supplemental
Figure 2.
RAT HEART TISSUE PROCESSING. After schedule 1
sacriﬁce, rat hearts were ﬁxed in 5% phosphate-
buffered formaldehyde and embedded in parafﬁn.
All hearts were sectioned in 3 transverse blocks: apex,
mid-heart, and base, and 4-mm sections from each
level examined by histology and immunohistochem-
istry. Isoprenaline-injected rats for each of the time
points (day 0 equivalent to 6 h after injection), days 1
to 7 and day 14 (n ¼ 7 per group) was compared with
saline-injected control rats (n ¼ 7 per group), that is,
70 animals in total. Because some deaths occurred on
injection in our designed groups, the number of ani-
mals available for each group was 5 to 7 animals as
indicated in Results. In additional experiments,
hearts were snap frozen for gene expression analysis
(control, saline-injected animals, and animals sacri-
ﬁced on day 3 and day 14 after induction of takotsubo
cardiomyopathy).
HISTOPATHOLOGY. Hematoxylin and eosin–stained
sections from the mid-heart, where the wall motion
abnormality and subendocardial hemorrhage were
observed, were scored semiquantitatively in a blin-
ded manner for histological/pathological changes by
an experienced consultant pathologist (K.K.). Arbi-
trary scores of 0, 1, and 2 were given for hemorrhage,
immune/inﬂammatory cellular inﬁltrates, eosino-
philic ﬁber staining areas, and degenerate myoﬁbrils/
ﬁber atrophy where the scoring system was deﬁned as
0 ¼ no lesions, 1 ¼ scattered/patchy/little present,
and 2 ¼ readily identiﬁable throughout the section. In
some sections, hemosiderin was identiﬁed in macro-
phages and conﬁrmed by Prussian blue stain, and was
scored on a scale of 0 to 2 (Supplemental Figure 3).
Most insults occurred in regional areas of the section
as illustrated in Supplemental Figure 3.
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CHEMISTRY. Sections were deparafﬁnized, micro-
waved in citrate buffer (pH 6.0), and endogenous
peroxidase activity quenched by incubation with 3%
H2O2. Neutrophil counts were determined from he-
matoxylin and eosin–stained sections by morphology.
Macrophages and T cells were detected by anti-CD68
antibodies (ED1, rat and KP1, human) (Abcam, Cam-
bridge, United Kingdom) and anti-CD3 antibodies
(MCA772GA, rat, Bio-Rad, Hercules, California; and
F7.2.38, human, Dako, Glostrup, Denmark), respec-
tively, and B cells by anti-CD20 antibody, L26
(Abcam) and the DAKO Envision Detection Kit K5007.
Speciﬁc brown staining was developed by incubation
with Chemate-DAB (Dako, Ely, United Kingdom).
Slides were counterstained with hematoxylin, and
nuclei blue stained with Scott’s Tap Water. The DAKO
G2-Double staining kit, K5361 (DakoCytomation,
Glostrup, Denmark) was used for staining with anti-
CD68 (ED1, rat and KP1, human) and the M1-
macrophage markers anti-major histocompatibility
complex (MHC) class II (OX-3, rat, TAI.1B5, human)
and inducible nitric oxide synthase (iNOS) (AB15323;
Bio-Rad) for rat, and SOCS3 (AB16030, Abcam) for
human and the M2-macrophage marker, anti-CD163
(ED2, Abcam for rat; EDHu-1, Bio-Rad for human),
according to the manufacturers’ instructions. Positive
staining was detected using diaminobenzidine/Liquid
Permanent-Red (DakoCytomation) (16). A negative
control where primary antibody was replaced by a
nonspeciﬁc IgG equivalent was included in all
analyses.
QUANTIFICATION OF NEUTROPHIL, MACROPHAGE,
AND T-CELL COUNTS. The mid-heart sections of rat
hearts was partitioned into 8 consecutive sections
(Supplemental Figure 4), and these were used to
quantify macrophage, T-cell, and neutrophil counts.
Each section was separated into 3 ﬁelds of view
(epicardium, mid-wall, and endocardium) to directly
compare areas. For human post-mortem tissue,
deﬁned sections approximately 3 cm  2 cm of
myocardial tissue was used. Intact CD68-positive
cells were counted, and absolute counts represent
the mean number of macrophages from each of the 8
sections of rat tissue. The entire area of human post-
mortem tissue was considered, and the average
macrophage number per ﬁeld determined from 15
ﬁelds per section was determined. Counts were
repeated until 3 consecutive values were obtained
with a margin of error of 5%. A similar technique
was used to count the CD3-positive T cells and neu-
trophils per area. Both the intraobserver and inter-
observer variation were found to be <5% (p < 0.002).The number of double-positive cells were counted
and expressed as a percentage of total macrophages.
QUANTIFICATION OF SERUM AND TISSUE CYTOKINES.
Serum samples collected from blood derived on car-
diac puncture at the time of sacriﬁce were analyzed
for tumor necrosis factor (TNF)-a, interleukin (IL)-6,
and IL-10 as determined by DuoSet enzyme-linked
immunosorbent assay kits from R&D Systems (Min-
neapolis, Minnesota) according to the manufacturer’s
instructions. Cytokine levels in the myocardial
tissue were determined by quantitative polymerase
chain reaction (qPCR). Tissues were homogenized in
TRIzol reagent (Sigma-Aldrich, St. Louis, Missouri)
and cDNA synthesis carried out from 1 mg of RNA
using a Tetro cDNA Synthesis Kit (Bioline, London,
United Kingdom). qPCR was performed using a Light
Cycler 480 (Roche, Basel, Switzerland), and gene
expression of TNF-a, il-6 and il-10, was determined in
relation to housekeeping gene HPRT. Groups
analyzed consisted of control, saline-injected animals
(n ¼ 10), isoprenaline-injected animals sacriﬁced 3
days after injection (n ¼ 9), and isoprenaline-injected
animals sacriﬁced 14 days after injection (n ¼ 5).
STATISTICAL ANALYSES. The Mann-Whitney U test
was used to compare the macrophage, neutrophil,
and T-cell counts/heart section. Pearson’s correlation
coefﬁcient determined the signiﬁcance of a correla-
tion between macrophages and their subtypes with
heart EF. All values are reported as mean  SD. A




To determine initially the type and time course of the
myocardial inﬂammatory changes in the experi-
mental model of stress-induced cardiomyopathy,
sections of rat heart were characterized histologically.
Six hours after administration of isoprenaline to rats,
histopathological examination revealed localized
subendocardial hemorrhage in the mid-ventricular
region of the heart (maximum histopathological
score 1.9) (Figure 1A) and post-day 5 showed an
increase in hemosiderin-containing phagocytic cells
(conﬁrmed by Prussian blue stain) (Supplemental
Figure 3D), supporting a resolution of injury. An im-
mune cell/inﬂammatory inﬁltrate was evident after 6
h, peaking at days 3 to 4 showing scattered, but later,
obvious inﬁltrates in regional areas, subsiding by day
5 (Figure 1B, Supplemental Figure 3). This inﬁltrate
correlated with prevalence of degenerate myoﬁbers
where histological scores peaked at day 4, subsiding
FIGURE 1 Histological Characterization of Mid-Heart Sections of Control Rats and From Rats After Induction of
Takotsubo Cardiomyopathy
Histological characterization of hematoxylin and eosin–stained mid-heart sections of control rats and from rats over the time course (0 to 14
days) after induction of takotsubo cardiomyopathy show a temporal immune/inﬂammatory cellular inﬁltrate. Sections of heart tissue were
semiquantitatively scored by a consultant histopathologist (K.K.) blinded to the study. Arbitrary scores of 0, 1, and 2 were given for (A)
hemorrhage (gray bars) or presence of hemosiderin-containing phagocytic cells (white bars), (B) immune/inﬂammatory cellular inﬁltrates,
(C) degenerate myoﬁbrils/myoﬁber atrophy, and (D) eosinophilic myoﬁbers. The number of animals per group were as follows; control n ¼
7, day 1 n ¼ 6, day 2 n ¼ 6, day 3 n ¼ 7, day 4 n ¼ 6, day 5 n ¼ 7, day 6 n ¼ 6, day 7 n ¼ 5, and day 14 n ¼ 5 animals. Statistical difference in
histological scores between control rats and those injected with isoprenaline were calculated with p values denoted above each time point bar.
Values in bold indicate statistically signiﬁcant differences compared with the control group.
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770at day 5. Beyond day 5, ﬁber atrophy was more
evident, then decreased by day 14 (Figure 1C).
Hypereosinophilic myoﬁbers were observed, peaking
at day 6 when nuclear pyknosis was observed
(Figure 1D), although this change was found across the
14-day period examined. Fibrosis was also identiﬁed
in late-stage sections (days 6, 7, and 14), consistent
with the sequelae of earlier inﬂammatory changes.
Vascular proliferation was found in 50% of animals by
day 14. No gross changes in monocyte numbers or
histology of the spleen could be detected between the
animal groups.DETAILED CHARACTERIZATION OF IMMUNE CELL
INFILTRATE OVER TIME. The increase in immune/
inﬂammatory cell inﬁltrates observed by histological
analysis over the time course of disease was exam-
ined in more detail by speciﬁc cell characterization
deﬁning the macrophages, neutrophils, and T-cell
counts within the rat mid-heart sections. Six hours
following isoprenaline injection, early neutrophilic
inﬁltrates predominated, peaking at day 1 to 2 and
subsiding thereafter, typical of an inﬂammatory
response (Figure 2). Macrophage counts peaked at day
3 and were typically found in regional clusters.
FIGURE 2 Immunohistochemical Analysis Following Induction of Stress-Induced Takotsubo-Like Cardiomyopathy
Immunohistochemical analysis demonstrates progressive neutrophil and macrophage inﬁltration into myocardial tissue (day 0 to 14) following
induction of stress-induced takotsubo-like cardiomyopathy. Representative examples of neutrophil (A) and macrophage (CD68-positive
cells) (B) staining in mid-region rat myocardial tissue, original magniﬁcation 400. Neutrophil (C) and macrophage (D) cell counts in the mid-
region of saline injected (control) and isoprenaline injected rat hearts (day 0 to 14). Values represent mean counts  SD in 24 ﬁelds of view
from deﬁned areas as described in the Methods section. The number of animals per group were as follows: control n ¼ 7, day 1 n ¼ 6, day 2
n ¼ 6, day 3 n ¼ 7, day 4 n ¼ 6, day 5 n ¼ 7, day 6 n ¼ 6, day 7 n ¼ 5, and day 14 n ¼ 5 animals. Statistical difference in mean number of
neutrophil and macrophage counts between control rats and those injected with isoprenaline were calculated with p values denoted above
each time point bar. Values in bold indicate statistically signiﬁcant differences compared with the control group.
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771Macrophage inﬁltrates subsided by day 5, but were
still evident at day 14 and did not return to baseline
levels, consistent with the time scale of the immune
cell inﬁltrate noted on histological assessment. We
observed no detectable T-cell inﬁltrates over the time
course examined.
Cardiac function as determined by the change in
percentage EF pre- and post-isoprenaline injection,
deteriorated immediately after disease induction,
and partially recovered thereafter, although not to
baseline (Supplemental Figure 2). The most signiﬁ-
cant decline in cardiac function was observed at the
6-h post-induction time point and thus preceded
macrophage inﬁltration and the time of peak inﬂam-
matory cell inﬁltrate.COMPARISONS OF THE PROPORTION OF M1 AND M2
MACROPHAGE SUBTYPES OVER THE COURSE OF
DISEASE. Given the increase in macrophage numbers
in heart sections of our experimental model of
takotsubo-like cardiomyopathy, it was important to
characterize their inﬂammatory phenotype. The pro-
portions of M1 (proinﬂammatory tissue destructive
macrophages expressing markers iNOS and MHC class
II) and M2 (CD163-positive anti-inﬂammatory, tissue
reparative/proﬁbrotic macrophages) (11,12) were
therefore examined (Figure 3A).
The percentage of MHC class II–positive macro-
phages and iNOS-positive macrophages, indicative of
M1 cells, increased over time after disease induction
(Figures 3B and 3C), peaking at day 4. The percentages
FIGURE 3 Double Immunostaining of Mid-Heart Sections Showing M1-Activated and M2-Positive Macrophages
Double immunostaining of mid-heart sections show a greater predominance of M1-activated macrophages over time with little change in percentage of M2-positive
macrophages. Total macrophages were detected by anti-CD68 and liquid permanent red staining (red), whereas macrophage activation markers were identiﬁed by the
relevant antibodies and DAB staining (brown). Macrophage-rich areas were analyzed as outlined in Methods. Examples of double-stained macrophages are highlighted
by arrows in A. Original magniﬁcation 400. Changes in percentages of double-stained macrophages over time for inducible nitric oxide synthase (iNOS) (B), major
histocompatibility complex (MHC) class II (C), and CD163 (D). The number of animals per group were as follows; control n ¼ 6, day 1 to 14 n ¼ 5 for each time point.
Statistical difference in the percentage iNOS, MHC class II, and CD163-positive macrophages between control rats and those injected with isoprenaline were calculated
with p values denoted above each bar. Values in bold indicate statistically signiﬁcant differences compared with the control group.
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772decreased between day 4 and 5 and then demon-
strated a second peak of increase at days 6 to 14
consistent with the increase in total macrophage
counts at that time and a classic inﬂammatory
response.
The percentage of CD163-positive M2 macrophages
showed a very different pattern. They increased from
day 0 to day 1, suggesting increased macrophage
activation. The percentage did not change signiﬁ-
cantly from day 1 to day 6, but fell on day 7 of disease
(Figure 3D).
To determine whether there was a relationship
between the total macrophage counts or the per-
centage of M1 and M2 macrophages and recovery of
cardiac function, we correlated the macrophage
numbers or M1/M2 percentages with percentage left
ventricular EF determined before culling (Figure 4).
There was no signiﬁcant correlation between the
level of total myocardial macrophage inﬁltration orpercentage M1 macrophages and the heart EF
(R2 ¼ 0.003; p ¼ 0.885 total macrophages; R2 ¼ 0.114;
p ¼ 0.259, iNOS-positive M1 macrophages; and R2 ¼
0.049; p ¼ 0.469, MHC class II–positive M1 macro-
phages). There is a signiﬁcant correlation (R2 ¼ 0.383;
p ¼ 0.018) between the percentage of M2 macro-
phages and percentage EF, indicating that a greater
preponderance of M2 cells improved recovery of car-
diac function.
LOCAL AND SYSTEMIC CYTOKINE CHANGES OVER
THE COURSE OF DISEASE. The levels of pro- and
anti-inﬂammatory cytokines were also analyzed post-
isoprenaline injection and compared with control rats
to determine whether local and systemic inﬂamma-
tion was apparent and could contribute to the
underlying macrophage polarization. Systemic
cytokine levels were low (IL-6 and IL-10) or unde-
tectable (TNF-a) with or without induction of
takotsubo-like cardiomyopathy. At day 3 and day
FIGURE 4 Correlations Between the Total Macrophage Counts or the Percentage M1 and M2 Macrophages and Recovery of
Cardiac Function
Correlations between the total macrophage counts or the percentage M1 and M2 macrophages and recovery of cardiac function as determined
by percentage left ventricular ejection fraction (EF). The total number of macrophages (A) or percentage of iNOS (B) and MHC class II–
positive (C)M1 macrophages and CD163-positive (D)M2-like macrophages was determined from immunohistochemical analysis and correlated
with the percentage ejection fraction before cull. A total of 13 animals were analyzed. The coefﬁcient of determination (R2) and p value were
determined by Pearson’s correlation test.
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 3 , N O . 6 , 2 0 1 8 Wilson et al.
D E C E M B E R 2 0 1 8 : 7 6 6 – 7 8 Takotsubo Cardiomyopathy and Myocardial Inﬂammation
77314 post-induction, IL-6 and IL-10 systemic levels were
elevated over control animals (Figures 5A and 5B),
although this did not reach statistical signiﬁcance
(IL-6 day 3 p ¼ 0.0952, IL-6 day 14 p ¼ 0.0754; IL-10
day 3 p ¼ 0.2103, IL-10 day 14 p ¼ 0.1904). Gene
expression levels for IL-6 and IL-10 in myocardial
tissue were also greater post-disease induction
(Figures 5C and 5D), but again, this increase did not
reach statistical signiﬁcance (IL-6 day 3 p ¼ 0.3951,
IL-6 day 14, p ¼ 0.4739; IL-10 day 3 p ¼ 0.4815, IL-10
day 14 p ¼ 0.5000). Gene expression levels for TNFa
were on the limit of detection by qPCR for both con-
trol and takotsubo-like cardiomyopathy animals (data
not included).
Overall, these results in our experimental model
suggest a characteristic ongoing inﬂammatory
response within the rat myocardium, with early and
prominent neutrophil inﬁltration, followed by M1
proinﬂammatory macrophages.CHARACTERIZATION OF INFLAMMATORY RESPONSES IN
HUMAN POST-MORTEM TAKOTSUBO CARDIOMYOPATHY
PATIENTS. To determine whether such an inﬂamma-
tory component observed in a rat model could also be
identiﬁed in post-mortem samples of human takot-
subo cardiomyopathy patients, myocardial tissue
from 2 patients (Patient #1 deceased 5 h and Patient
#2 deceased 5 days post-presentation) was assessed.
The myocardium used for assessment was unaffected
by any visible macroscopic ﬁbrotic changes or
infarction. Occasional small areas of lymphocytic and
macrophage inﬁltration were evident in the inter-
stitium and within areas of myocytes underlying the
pericardial fat. Focal subendocardial hemorrhage was
also present. For control hearts with no known heart
condition and no post-mortem ﬁndings of heart dis-
ease, less prominent lymphocytic and macrophage
inﬁltration was observed histologically in all cases
(n ¼ 4).
FIGURE 5 Analysis of Systemic and Myocardial Cytokine Levels in Control Animals and Those With Takotsubo-Like Cardiomyopathy
Analysis of systemic and myocardial cytokine levels in control animals and those with Takotsubo-like cardiomyopathy at day 3 (d3) and day 14
(d14) are shown. Serum levels of IL-6 (A) and IL-10 (B) are mean pg/ml levels  SD; gene expression levels of IL-6 (C) and IL-10 (D). Groups
analyzed consisted of control, saline-injected animals (n ¼ 10), isoprenaline-injected animals sacriﬁced 3 days after injection (n ¼ 9), and
isoprenaline-injected animals sacriﬁced 14 days after injection (n ¼ 5). Values are mean fold change over control animals  SD. Values above
each bar indicate p values compared with control animals. IL ¼ interleukin.
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774Immunohistochemical analysis demonstrated a
scattered distribution of CD3-positive cells in both
takotsubo cardiomyopathy patients’ post-mortem
myocardial tissues, whereas control tissues demon-
strated sparse cell positivity and 1 case that revealed
scattered groups of CD3-positive cells. Control tissue
showed no positive staining for CD20 (B lympho-
cytes), whereas both patients revealed a scattered
CD20 cell positivity. Patient #2, deceased 5 days
following presentation, demonstrated a scattered
macrophage distribution with occasional aggregated
clusters of macrophages in the subendothelium and
subpericardial regions (Figure 6), whereas aggregated
clusters were less obvious in Patient #1, deceased 5 h
after onset of symptoms or in control subject
myocardium.More quantitative analysis of macrophage counts
showed the average macrophage number per ﬁeld
in patients was signiﬁcantly higher than in control
subjects (10.6  2.8 Patient #1; 27.01  16.1 Patient
#2, vs. 6.7  5.4 control tissue; p < 0.05). To
compare the M1/M2 phenotypes of macrophages
between groups and relate results to that of our
experimental model, double immunohistochemistry
was performed. As with our experimental model,
there was a greater proportion of M1 macrophages
(CD68/HLADR or CD68/SOCS3 positive) in myocar-
dial tissue from takotsubo cardiomyopathy patients
when compared with control tissue, again reﬂecting
a potential proinﬂammatory response (Figure 6).
By contrast, there was no obvious difference in
the proportion of M2, CD163-positive myocardial
FIGURE 6 Post-Mortem Myocardial Tissue From Takotsubo Patients
Post-mortem myocardial tissue from takotsubo patients show the presence of macrophages and demonstrate an increase/predominance of M1
macrophages. Macrophage staining (CD68-positive cells) showing, as indicated by arrows: (A) scattered macrophages in the subendothelial
area of the myocardium in a control subject with no underlying heart condition, (B) very few subendothelial aggregates of macrophages
in patient 1 deceased 5 h after presentation with takotsubo cardiomyopathy, and (C) subpericardial aggregates of macrophages in the
myocardial tissue from patient 2 with takotsubo cardiomyopathy deceased 5 days after presentation. Original magniﬁcation 400.
(D) Percentage of CD68-positive macrophages staining for M1 markers HLADR and SOCS3, and M2 marker CD163 in patients with
takotsubo cardiomyopathy (TTC) (n ¼ 2) and age/sex-matched control subjects (control) (n ¼ 4).
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775tissue macrophages between patients and control
subjects.
DISCUSSION
Several mechanisms have been implicated in patho-
genesis of takotsubo cardiomyopathy, including cor-
onary artery spasm, microvascular dysfunction, and
excessive release of catecholamines in response to
stress (17,18). None of these mechanisms, however,
has been conclusively proven to be responsible for
the disease solely or in combination, accounting for
the lack of targeted therapies. Inﬂammation has been
implicated from noninvasive imaging, because of the
intense myocardial edema observed on cardiac mag-
netic resonance imaging (3,5), and inﬂammatory
changes in the heart have been reported frombiopsies of patients, albeit these were taken from the
right ventricular myocardium (19). Proteomic analysis
of apical cardiac tissue in an experimental model also
proposes inﬂammation might be involved (12), and an
increase in macrophage inﬁltration has been observed
24 h after disease induction (20). To characterize fully
the inﬂammatory aspects of the disease, we used a
well-published experimental model of stress-induced
takotsubo-like cardiomyopathy, initiated in the
absence of ischemic or pathogen-induced inﬂamma-
tory insults, to follow a detailed time course of in-
ﬂammatory changes in myocardial tissue, focusing on
the inﬁltration of inﬂammatory macrophages and the
subtypes present, and whether inﬂammation was
localized or systemic. Our experimental model elim-
inates the complications of any confounding clinical
conditions and comorbidities that are found with
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776patients and, for the ﬁrst time, provides a model
whereby we can discriminate and directly compare
speciﬁc inﬂammatory responses over a controlled
time period. First, we demonstrate a classic inﬂam-
matory response upon disease induction, with early
inﬁltration of neutrophils followed by an increase in
macrophages and an increase in cytokine gene
expression. Second, the increase in myocardial mac-
rophages corresponded to the increase in the per-
centage of those with a proinﬂammatory M1
phenotype. Third, the percentage of M2 macrophages
did not increase signiﬁcantly over time, but individ-
ual levels correlated with recovery in cardiac func-
tion. Fourth, the inﬂammation appears localized with
no substantial increase in circulating cytokine levels;
and lastly, the inﬂammatory cell characterization in
our experimental rat myocardial tissue was recapit-
ulated in post-mortem myocardial tissue from takot-
subo cardiomyopathy patients.
Macrophage functions help maintain cardiovascu-
lar health; however, following an insult, M1 macro-
phages, which are associated with tissue damage,
dominate, and their inﬂammatory actions can
unleash functions that promote disease (13,14).
Subsequently, M2 macrophages produce anti-
inﬂammatory, proangiogenic, and proreparative fac-
tors (e.g., vascular endothelial growth factor, and
TGF-b1) and engulf apoptotic cells to facilitate repair
(13,14). Following induction of stress-induced takot-
subo-like cardiomyopathy, the inﬁltrating macro-
phages show a temporal increase in their M1
activation and proinﬂammatory characteristics peak-
ing at day 4 with a second peak at day 7, a time point
where there was a corresponding decrease in the
percentage of M2-activated cells. A normal heart has
its own tissue-resident cardiac macrophages that
display a M2-like, CD163-positive phenotype (21). The
drop in percentage of CD163-positive macrophages
may reﬂect exhaustion of these tissue-resident cells
after myocardial injury and the replacement by
monocyte-derived macrophages inﬁltrating from the
circulation (22,23). The failure of an up-regulation in
the percentage of M2 macrophages at days 5 to 14
strongly contrasts with that observed with models of
MI where there is a peak of M1 macrophages and a
robust increase in systemic inﬂammatory cytokine
levels. This is followed by increased M2 macrophages
(days 5 to 7) that initiates myocardial remodeling and
potentially scarring (24,25). By contrast, in our
takotsubo-like experimental model, we observe a
peak of M1 macrophages, but no secondary peak of
M2 reparative macrophages, and low and no signiﬁ-
cant increase in circulating cytokine levels. This lackof the timely suppression and spatial containment of
the inﬂammatory response to the myocardium in our
takotsubo-like model may perpetuate into a long-
term low-grade chronic inﬂammatory state. This
supports our recently demonstrated clinical concept
of continued and persistent symptoms rather than
complete resolution of disease observed in takotsubo
patients (26,27). Indeed, we show that the increase in
percentage EF, as a measure of cardiac function,
correlated positively with the percentage of M2
macrophages. This suggests that shifting the balance
from M1 to M2 macrophages by speciﬁc therapies may
be beneﬁcial by promoting myocardial repair and
functional improvement post-takotsubo. These ideas
need to be validated in future pre-clinical
experiments.
In our study, we did not set out to determine
whether the inﬂammatory response observed was
the initial cause of the disease or a response to
an insult. Given that the greatest drop in cardiac
function (as determined by percentage EF) is imme-
diately after disease induction and precedes the peak
of neutrophil and macrophages into the myocar-
dium, we consider that the nonresolving inﬂamma-
tion is a secondary feature of disease. It remains
unclear what would initiate the inﬂammatory
response in the human disease although mechanical
or catecholamine-induced myocyte stress in the
akinetic/dyskinetic myocardial regions has been
suggested as a potential cause (17–19). Regardless
of the instigating trigger, the persistent presence of
proinﬂammatory cells such as M1-type macrophages
would be expected to contribute to the longer-term
pathology.
As with rat myocardium, myocardial tissue from
Patient #2, deceased 5 days after diagnosis, revealed
more prominent inﬁltrates of macrophages when
compared with Patient #1 deceased 5 h after diag-
nosis, suggesting a primary insult in humans could
also result in a progressive inﬂammatory response,
albeit a greater number of post-mortem studies are
required to conﬁrm this. Our takotsubo post-mortem
hearts exhibit a predominance of M1 proin-
ﬂammatory macrophages that could initially be dis-
missed as being associated with other cardiac
pathologies, such as coronary artery disease. In the
setting of MI, it is well accepted that macrophage
inﬁltrates track to a characteristic localized area of
ischemia-induced injury/scarring. By contrast, our
ﬁndings suggest that in takotsubo, localized M1
macrophage inﬁltrates occur within viable myocardial
areas. This may be a potential marker of takotsubo
even when other well-documented cardiac
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Low-grade
myocardial inﬂammation is a distinguishing feature following
both experimental and clinical stress-induced takotsubo cardio-
myopathy. Our results establish that a proinﬂammatory (M1
macrophages) phenotype prevails following a decline in cardiac
function, which may contribute toward the morbidity and
increased mortality associated with this condition in a subset of
patients.
TRANSLATIONAL OUTLOOK: No current therapy exists for
takotsubo cardiomyopathy. Our study suggests that targeting
the myocardial inﬂammatory process at the onset of disease may
have merit as a clinical intervention to alleviate the long-term
persistent symptoms that occur in a number of patients.
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777pathologies are present. Imaging of macrophages by
ultrasmall superparamagnetic iron oxides in the
myocardium of takotsubo patients in the acute phase
could provide further indications.
Myocardial biopsies from takotsubo cardiomyop-
athy patients have previously supported the idea of
a potential inﬂammatory response. In a study by
Wittstein et al. (28), of the 5 patients with takotsubo
cardiomyopathy who underwent right ventricular
endomyocardial biopsy, 4 had interstitial inﬁltrates
consisting primarily of mononuclear lymphocytes
and macrophages and contraction bands without
myocyte necrosis. A further histopathological anal-
ysis of a myocardial biopsy sample obtained from a
71-year-old woman, who died 8 h after onset of
takotsubo, revealed multiple necrotic lesions,
monocytes and neutrophil inﬁltration, and hemor-
rhage (29), whereas the presence of inﬂammatory
cells (mainly monocytes) and disrupted myoﬁbers
has also been reported (30,31). Unlike our current
study, however, none of these studies deﬁnitively
compared biopsies with those of control subjects
with no underlying heart pathology, or deﬁned the
nature of the inﬂammatory cells or phenotype of
macrophages.
There are no consensus recommendations for long-
term management of takotsubo cardiomyopathy to
prevent recurrences, and the current clinical man-
agement of these patients presents signiﬁcant clinical
equipoise. Long-term treatment with b-blockers, or
calcium channel blockers and aspirin did not improve
left ventricular function in a multicenter retrospec-
tive study (32). From a translational perspective,
our results point to an inﬂammatory component,
suggesting that immune-modulation therapies may
be a therapeutic avenue in this condition, and inter-
vention studies should be considered.
STUDY LIMITATIONS. The experimental model used
is a surrogate and may not fully reﬂect clinical human
takotsubo cardiomyopathy where there are multiple
predisposing and/or precipitating factors. Catechol-
amines have been described as a precipitating factor
in human takotsubo development, but they are not
the only one. This is currently the only well-
published model for this stress-induced disorder,
providing us with a unique opportunity to temporally
assess the inﬂammatory response in the absence
of multiple predisposing factors and comorbidities
that can complicate the analysis in patients.
The number of post-mortem cases with Takotsubocardiomyopathy in this study was limited to
2 patients, and therefore will require conﬁrmation
in larger post-mortem datasets.
CONCLUSIONS
We demonstrate for the ﬁrst time that a classic
inﬂammatory response with predominant M1 macro-
phage inﬁltration of the myocardium, without a
conventional switch to M2 macrophages is a charac-
teristic of experimental takotsubo-like cardiomyopa-
thy. This results in low-grade chronic inﬂammation
in myocardial tissue that has potential to drive
the long-term and persistent symptoms observed in
takotsubo patients. Similar inﬂammatory changes
were observed in otherwise macroscopically normal
myocardium of post-mortem takotsubo human
hearts, pointing to a potential new marker of this
condition and suggesting inﬂammatory modulators,
for example, switching the balance from M1 to M2
macrophages may be a therapeutic option.
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